Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L. reuteri DSM 17938 for Prevention of AAD in Children
NCT02871908Phase 4Completed
- Sponsor
- Medical University of Warsaw
- Start
- Dec 2016
- Primary completion
- Mar 2018
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of Lactobacillus reuteri DSM 17938 in antibiotic-associated diarrhea (AAD), sponsored by Medical University of Warsaw. Started Dec 2016; status: completed.
02
Drugs
Lactobacillus reuteri DSM 17938
03
Conditions
antibiotic-associated diarrhea (AAD)
Beyond the preview
Go deeper on NCT02871908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02871908.